Top FDA drug regulator plans to depart weeks into job
The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
Rick Pazdur to replace George Tidmarsh at FDA drug center
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to…
US to remove warnings from menopause hormone therapy
The United States will remove strong safety warnings on many hormone therapies used to alleviate menopausal symptoms, saying…
Trump hosts Syrian President Ahmad al-Sharaa at the White House in first-of-its-kind meeting
President Donald Trump welcomed Syrian President Ahmad al-Sharaa after lifting sanctions imposed on Syria, which had been a…
FDA removing warning from hormone-based menopause drugs
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry…
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’
WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…
FDA bans unapproved fluoride drugs for kids, citing health risks
The U.S. Food and Drug Administration has moved to end a decades-old dental habit, restricting the sale of…
FDA vaccine chief Vinay Prasad leaves following criticism from Laura Loomer
WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief…
US health officials crack down on kratom-related products after complaints from supplement industry
WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added…
Sarepta stock falls on FDA gene therapy Elevidys comment
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…